MnM Healthcare Industry

𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐃𝐢𝐚𝐛𝐞𝐭𝐞𝐬 𝐌𝐚𝐧𝐚𝐠𝐞𝐦𝐞𝐧𝐭: 𝐖𝐡𝐞𝐫𝐞 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 𝐌𝐞𝐞𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐫𝐨𝐰𝐭𝐡 𝐟𝐨𝐫 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐋𝐞𝐚𝐝𝐞𝐫𝐬 📚 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞: https://lnkd.in/d5MQCg2A The global digital diabetes management market in terms of revenue was estimated to be worth $18.9 billion in 2023 and is poised to reach $35.8 billion in 2028, growing at a CAGR of 13.6% ◽ 𝐃𝐫𝐢𝐯𝐞𝐫: Advent Of Artificial Intelligence In Diabetes Care Devices ◽ 𝐑𝐞𝐬𝐭𝐫𝐚𝐢𝐧𝐭: High cost of devices and lack of reimbursement in developing countries ◽ 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐲: Increasing diabetes-related health expenditure ◽ 𝐂𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞: Low penetration in developing economies 🌐 𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚 𝐰𝐢𝐥𝐥 𝐠𝐫𝐨𝐰 𝐛𝐲 𝐡𝐢𝐠𝐡𝐞𝐬𝐭 𝐂𝐀𝐆𝐑 𝐢𝐧 𝐭𝐡𝐞 𝐝𝐢𝐠𝐢𝐭𝐚𝐥 𝐝𝐢𝐚𝐛𝐞𝐭𝐞𝐬 𝐦𝐚𝐧𝐚𝐠𝐞𝐦𝐞𝐧𝐭 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲, 𝐛𝐲 𝐫𝐞𝐠𝐢𝐨𝐧. North America will grow by highest CAGR in the digital diabetes management market, by region, followed by Europe, Asia Pacific, Latin America, Middle East & Africa. The highest CAGR of North America can be attributed to the growing adoption of connected diabetes management devices, increasing adoption of diabetes management and obesity apps, growing demand for technologically advanced solutions, increased acceptance of digital diabetes solutions from payers, government initiatives to promote digital health, and rising awareness on self-diabetes management in the region. 🌐 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞: Medtronic  BKK B. Braun Melsungen AG Dexcom Abbott  Pensionskasse der F. Hoffmann-La Roche AG Insulet Corporation  Tandem Diabetes Care  Ascensia Diabetes Care LifeScan Tidepool  AgaMatrix  Glooko wayForward (acquired by DarioHealth Corp.)  One Drop Ypsomed Holding AG  ARKRAY, Inc.  ACON Laboratories Care Innovations®, Health2Sync 智抗糖  Emperra GmbH E-Health Technologies  Azumio Inc.  decide Clinical Software GmbH  Pendiq GmbH  BeatO

𝐓𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐥𝐞𝐮𝐤𝐚𝐩𝐡𝐞𝐫𝐞𝐬𝐢𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐬 𝐚𝐧𝐭𝐢𝐜𝐢𝐩𝐚𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 𝐔𝐒𝐃 1020 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2028 𝐟𝐫𝐨𝐦 𝐔𝐒𝐃 200 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 2023, 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 38.1% 📚 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞: https://lnkd.in/dZcu-nBh One of the key trends in the leukapheresis market is the increasing use of leukopaks in CAR T-cell therapy. CAR T-cell therapy is a type of immunotherapy that uses the patient's own immune cells to fight cancer. It is a promising new treatment for leukemia and other blood cancers. Leukopaks are used to collect the patient's immune cells, which are then modified to fight cancer. Other trends in the #leukapheresis market include the increasing demand for leukopaks in personalized medicine and the development of new leukopak collection and storage methods. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞: Asahi Kasei Fresenius Medical Care Haemonetics TERUMO BCT LTD. Macopharma Miltenyi Biotec Discovery Life Sciences  Charles River Laboratories Caltag Medsystems Ltd. Lonza Zenbio

𝐑𝐨𝐛𝐨𝐭𝐢𝐜 𝐑𝐚𝐝𝐢𝐨𝐭𝐡𝐞𝐫𝐚𝐩𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐰𝐨𝐫𝐭𝐡 $1.9 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2028 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞: https://lnkd.in/dxA8byj9 The global size of robotic radiotherapy market in terms of revenue was estimated to be worth $1.1 billion in 2023 and is poised to reach $1.9 billion by 2028, growing at a CAGR of 11.9% The growth of this market is majorly driven by factors such as the increasing demand for non-invasive treatments, a rise in #cancer prevalence, and the widespread adoption of radiotherapy therapy. Additionally, escalating healthcare spending in developing nations, augmented government and private investments, as well as the increasing adoption of radiation therapy, contribute to the market's growth trajectory during the forecast period. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞: Siemens Healthineers Varian Medical Systems Pacific Inc Elekta Accuray IBA WORLDWIDE TRADING COMPANY ViewRay, Inc.

𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐄𝐃𝐈 𝐌𝐚𝐫𝐤𝐞𝐭 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 2029: 𝐄𝐬𝐬𝐞𝐧𝐭𝐢𝐚𝐥 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐟𝐨𝐫 𝐄𝐱𝐞𝐜𝐮𝐭𝐢𝐯𝐞 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐲 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 👉 https://lnkd.in/dymP-Fpc 𝐓𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐡𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐄𝐃𝐈 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐬 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 𝐔𝐒𝐃 7.1 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2029 𝐟𝐫𝐨𝐦 𝐔𝐒𝐃 4.5 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 2024, 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 9.7% ◽ 𝐃𝐫𝐢𝐯𝐞𝐫: Government support for the expansion of healthcare IT ◽ 𝐑𝐞𝐬𝐭𝐫𝐚𝐢𝐧𝐭𝐬: Data security concerns ◽ 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐲: Increase in outsourcing of EDI services ◽ 𝐂𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞: End user limitations and requirements 🌐 𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚 𝐚𝐜𝐜𝐨𝐮𝐧𝐭𝐞𝐝 𝐟𝐨𝐫 𝐭𝐡𝐞 𝐥𝐚𝐫𝐠𝐞𝐬𝐭 𝐬𝐡𝐚𝐫𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐡𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐄𝐃𝐈 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐧 2023. The healthcare EDI market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2023, North America had the largest share of the healthcare EDI market. 🌐 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞: McKesson UnitedHealth Group  IBM  Cognizant  Boomi  True Commerce athenahealth  Axway  Experian Veradigm® The SSI Group, LLC  NTT DATA Comarch Availity LLC Quadax, Inc.  Waystar.  PLEXIS Healthcare Systems  Inovalon  123 EDI  Cirius Group Inc. Epicor Software Corporation  Osp Labs  Nalashaa Solutions  WNS  Pilotfish Cleo

PCR Technologies Market worth $21.89 Billion by 2030 📚 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞: https://lnkd.in/d2DW7ima 𝐓𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐏𝐂𝐑 𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐠𝐫𝐨𝐰𝐭𝐡 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭𝐞𝐝 𝐭𝐨 𝐭𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦 𝐟𝐫𝐨𝐦 𝐔𝐒𝐃 14.61 𝐁𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 2024 𝐭𝐨 𝐔𝐒𝐃 21.89 𝐁𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2030, 𝐝𝐫𝐢𝐯𝐞𝐧 𝐛𝐲 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 7.0%. 𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚 held the largest share of 44.5% of the PCR technologies market in 2023. The increasing incidence of infectious diseases and constant improvements in creating innovative #PCRtechnologies play a vital role in the #northamerican market growth. 🌐 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞: F.-M. Hoffmann Thermo Fisher Scientific Bio-Rad Laboratories QIAGEN  Takara Bio Inc.  Agilent Technologies Standard BioTools  Danaher Corporation  Abbott  Merck KGaA, Darmstadt, Germany  Illumina Bioneer  PerkinElmer  Sansure Biotech Inc.  Becton, Dickinson and Company  Analytik Jena

𝐍𝐞𝐱𝐭 𝐆𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐨𝐧 𝐒𝐞𝐪𝐮𝐞𝐧𝐜𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐖𝐨𝐫𝐭𝐡 $27.0 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2027 ☑️𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞: https://lnkd.in/dWFv2Q55 The global market, for next generation sequencing is estimated to grow to USD 27.0 billion by 2027 from USD 13.0 billion in 2022 with a projected growth rate of 15.7% from 2022 to 2027. 🔵𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Illumina Thermo Fisher Scientific PerkinElmer Agilent Technologies Oxford Nanopore Technologies BGI Genomics QIAGEN Roche Eurofins Scientific Finland Oy Brooks Automation Psomagen 10x Genomics Zymo Research Corp Takara Bio USA, Inc. Promega Corporation CD Genomics New England Biolabs Novogene Hamilton Company MEDGENOME BD CosmosID Genotypic Technology LGC

𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐈𝐓 𝐌𝐚𝐫𝐤𝐞𝐭 𝐖𝐨𝐫𝐭𝐡 $974.5 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2027 ☑️𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞: https://lnkd.in/dsTUq7BR The global healthcare IT market in terms of revenue was estimated to be worth $394.6 billion in 2022 and is poised to reach $974.5 billion by 2027, growing at a CAGR of 19.8% from 2022 to 2027. 🔵𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Optum Cerner Corporation Cognizant Change Healthcare Philips EPIC Systems Dell Technologies Allscripts Healthcare, LLC athenahealth GE HealthCare Oracle Wipro IBM eClinicalWorks Infor Conduent Conifer Health Solutions Nuance Communications 3M SAS Carestream Inovalon Practice Fusion InterSystems Tata Consultancy Services

𝐀𝐦𝐧𝐢𝐨𝐭𝐢𝐜 𝐏𝐫𝐨𝐝𝐮𝐜𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐰𝐨𝐫𝐭𝐡 $1,289 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2028 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞: https://lnkd.in/dgAJbt2J The global amniotic products market growth forecasted to transform from USD 900 million in 2023 to USD 1,289 million by 2028, driven by a CAGR of 7.4%.  The growth of this market is majorly driven by Growth in the target patient population and Rising incidence of burn injuries and increasing number of traumatic wounds. 🌐 𝐓𝐡𝐞 𝐔𝐊 𝐢𝐧 𝐄𝐮𝐫𝐨𝐩𝐞𝐚𝐧 𝐚𝐦𝐧𝐢𝐨𝐭𝐢𝐜 𝐩𝐫𝐨𝐝𝐮𝐜𝐭𝐬 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐭𝐨 𝐰𝐢𝐭𝐧𝐞𝐬𝐬 𝐭𝐡𝐞 𝐠𝐫𝐨𝐰𝐭𝐡 𝐫𝐚𝐭𝐞 𝐝𝐮𝐫𝐢𝐧𝐠 𝐭𝐡𝐞 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐩𝐞𝐫𝐢𝐨𝐝. The #europe amniotic products market is segmented into #Germany, #France, the #UK, and the Rest of Europe. Germany is registered the highest growth rate during the forecast period. The major factors contributing to the growth of this market are the high prevalence of diabetes and venous ulcers, rising in ophthalmic, orthopedic & wound cases in the UK, increasing R&D activities, strategic developments by key players, and the growing geriatric population. 🌐 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞: MiMedx (US), Smith+Nephew (UK), Organogenesis Inc. (US), Integra LifeSciences (US), Stryker (US), APPLIED BIOLOGICS. (US), Celularity Inc. (US), Corza Ophthalmology (US), Lucina BioSciences, LLC (US), and Next Biosciences. (South Africa). 🌎 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐭𝐡𝐚𝐭 𝐚𝐫𝐞 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐠𝐥𝐨𝐛𝐚𝐥𝐥𝐲 Zimmer Biomet Skye Biologics, Inc. BioTissue axogen StimLabs Arthrex Össur Amnio Technology Genesis Biologics Inc. ANIKA THERAPEUTICS S.R.L. Regenative Labs Katena Lab Aziyo Biologics, Inc. LifeCell International Pvt.Ltd Cerapedics Inc. Paragon 28 CONMED Corporation Orthofix Vericel® Corporation Organogenesis Holdings Inc. Bioventus Medline Industries, LP RTI Surgical® Arthrosurface Cook Medical Surgalign MTF Biologics Medtronic Orthofix Bacterin International, Inc. Treace Medical Concepts, Inc. Biocomposites NuVasive Globus Medical

𝐂𝐚𝐧𝐜𝐞𝐫 𝐏𝐫𝐨𝐟𝐢𝐥𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 $16.0 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2027 📚 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞: https://lnkd.in/ds7kzz73 The global cancer profiling market in terms of revenue was estimated to be worth $9.7 billion in 2022 and is poised to reach $16.0 billion by 2027, growing at a CAGR of 10.6% from 2022 to 2027. The growth in this market is driven by rising funding investments in cancer research and technological advancements in profiling technologies. In addition, the growing need for point-of-care diagnostics is expected to offer significant growth opportunities for market players. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Illumina QIAGEN NeoGenomics Laboratories Sysmex Corporation HTG Molecular Diagnostics Predictive Oncology Caris Life Sciences NanoString Technologies, Inc. Guardant Health Foundation Medicine Roche Thermo Fisher Scientific GenScript Arterys (Acquired by Tempus Labs) Hologic, Inc. Exact Sciences Laboratory Corporation of America Holdings Personalis, Inc. Boreal Genomics Strand Life Sciences Lucence ACT Genomics IMBdx Perthera Agendia

𝐖𝐞𝐚𝐫𝐚𝐛𝐥𝐞 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐰𝐨𝐫𝐭𝐡 $69.2 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 | 𝐆𝐫𝐨𝐰𝐢𝐧𝐠 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 11.2% 📚 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞: https://lnkd.in/dMEZwcAb The wearable healthcare devices market is valued at an estimated USD 40.7 billion in 2023 and is projected to reach USD 69.2 billion by 2028 at a CAGR of 11.2% during the forecast period. 🔶 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞: Apple Inc. (US), Fitbit (US), Abbott (US), Dexcom, Inc. (US), and Koninklijke Philips N.V. (Netherlands) & Others 🔶 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐭𝐡𝐚𝐭 𝐚𝐫𝐞 𝐨𝐩𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐠𝐥𝐨𝐛𝐚𝐥𝐥𝐲 KynLife Tokcalar Makina Yallys Technology Shenzhen XJC Electronics Co.,Ltd Transtek KONIG Technologies Co., Ltd. BlueX Microelectronics Corp. Ltd. Pervasive Dynamics Inc. Yawell Gapmatics Spectral Sense MGCOOL Jubilee Biotech The TouchPoint™ Solution Australia Things-Lab Shenzhen Lookcare Industrial Co.,Ltd. DESON Insulation ElectroniXchange EASYQUICK Shenzhen Xueban Interconnection Science and Technology Co., ltd. Pinaka Labs Shenzhen KCT Intelligence Technology Co.,Ltd. Superinteractiv Shenzhen Lefonry Technology Co., Ltd GMB Hi-temp. ER Battery Pack Bonnett Devo stores Huangshi Fusun Trade Co.,Ltd Shenzhen SuoYu Technology Co., Ltd RUBTOP Metals Rubber Co.,Ltd. Twisted Wrist Limited Shenzhen Wuyi Intelligent Technology Co.,Ltd Spaexo eIoT JOY SMARTWEAR Oriver Limited Persona3D hashswag.io EXCELIO TECHNOLOGY IoTone, Inc. #Wearables #smartwatch #healthcare